New concepts in the diagnosis and treatment of recent-onset polyarthritis

Joint Bone Spine

Volumn 72, Issue 2, 2005, Pages 119-123

  Raissouni, Nouha ^a   Gossec, Laure ^a   Ayral, Xavier ^a   Dougados, Maxime ^a  

^a Cochin Teaching Hospital ^*  (France)

Author keywords

Recent onset inflammatory joint disease; Treatment

Indexed keywords

CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

CHRONIC ARTHRITIS; CLINICAL TRIAL; DISEASE COURSE; HUMAN; POLYARTHRITIS; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; ARTHRITIS; RHEUMATOLOGY;

ARTHRITIS; HUMANS; RHEUMATOLOGY;

EID: 23844545640     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2004.04.009     Document Type: Short Survey

References (28)

1. Goldbach R., and Lipsky P.E. New concepts in the treatment of rheumatoid arthritis Annu Rev Med 54 2003 197 216
2. Lee D.M., and Weinblatt M.E. Rheumatoid arthritis Lancet 358 2001 903 911
3. Williamson A.A., and Mc Coll J.G. Early rheumatoid arthritis: can we predict its outcome? Intern Med J 31 2001 168 180
4. Gabriel S.E., Crowson C.S., Kremers H.M., Doran M.F., Turesson C., and O'Fallon W.M. Survival in rheumatoid arthritis: a population-based analysis of trends over 40:years Arthritis Rheum 48 2003 54 58
5. Combe B., and Dougados M. La polyarthrite rhumatoïde est morte. Vive la polyarthrite chronique ́volutive La Lettre du Rhumatologue n°277 2001 3 4
6. Weisman M.H. Newly diagnosed Rheumatoid arthritis Ann Rheum Dis 61 2002 287 289
7. Combe B. Evolution et pronostic de la polyarthrite rhumatoïde La Lettre du Rhumatologue n°277 (suppl) 1996 3 10
8. Combe B. Les facteurs de pronostic des rhumatismes inflammatoires au d́but de la maladie Rev Med Interne 17 1996 224 230
9. VisserR H., Le Cessie S., Vos K., Breedveld F.C., and Hazes J.M. How to diagnose rheumatoid arthritis early: a model for persistent (erosive) arthritis Arthritis Rheum 46 2002 286 290
10. Mariette X. Polyarthrite rhumatoïde: pathoǵnie et clinique La Lettre du Rhumatologue n° 288 2003 7 11
11. Meyer O., Labarre C., Dougados M., Goupille P.H., Cantagrel A., and Dubois A. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five-year radiographic damage Ann Rheum Dis 62 2003 120 126
12. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., and Cooper N.S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315 324
13. Rantapaa-Dahlqvist S., Jong W., Halmans G., Wadell G., Stendlund H., and Sundin U. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum 48 2003 2741 2749
14. Garnero P., Landewe R., Boers M., Verhoven A., Vanderlinden S., and Christgau S. Association of baseline levels of markers of bone and cartilage degradation with long term progression of joint damage in patients with early rheumatoid arthritis. The COBRA study Arthritis Rheum 46 2002 2847 2856
15. Lard L., Visser H., Speyer I., Vanderhorst-Bruisma I., Zwinderman A.H., and Breedveld F.C. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparaison of two cohorts who received different treatment strategies Am J Med 111 2001 446 451
16. Verstappen S., Jacobs J., Bijlsma J., Heurkens A., Booma-Frankfort C., and Borg E. Five years follow up of rheumatoid arthritis patients after early treatment with DMARD versus treatment according to the pyramid approach in the first year Arthritis Rheum 48 2003 1797 1807
17. Dougados M., Combe B., Cantagrel A., Goupille P., Olive P., and Schattenkirchner P. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52:week clinical trial of sulphasalazine and methotrexate compared with the single components Ann Rheum Dis 58 1999 220 225
18. Proudman S.M., Conaghan P.G., Richardson C., Griffiths B., Green M.J., and McGonagle D. Treatment of poor prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A and intraarticular corticosteroids compared with sulfasalazine alone Arthritis Rheum 43 2000 1809 1819
19. Calguneri M., Pay S., Caliskaner Z., Apras S., Kiraz S., and Ertenli I. Combination therapy versus monotherapy for the treatment patients with rheumatoid arthritis Clin Exp Rheumatol 6 1999 699 704
20. Mottonen T., Hannonen P., Korpela M., Nissila M., Kautiainen H., and Iilonen J. Delay to institution of therapy and induction of remission using single-drug or combination disease-modifying antirheumatic drug therapy in early rheumatoid arthritis Arthritis Rheum 46 2002 894 898
21. Jaarsveld C., Jahangier Z., Jacobs J., Blaauw A., Albada-Kuipers G., and Borg E. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis Rheumatology 39 2000 1374 1382
22. Bathon J.M., Martin R.W., Fleischmann R.M., Tesser J.R., Schiff M.H., and Keystone F.C. A comparaison of etanercept and methotrexate in patients with early rheumatoid arthritis N Engl J Med 343 2000 Nov 30 1586 1663
23. Weinblatt M.E., Kremer J.M., Bankhurst A.D., Bulpitt K.J., Fleischmann R.M., and Fox R.I. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate N Engl J Med 340 1999 Jan 3028 253 259
24. Maini R.N., Breedveld F.C., Kalden J.R., Smolen J.S., Davis D., and Macfarlane J.D. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low- dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 41 1998 1552 1563
25. Lipsky P.E., Van der Heijde D.M., St Clair E.W., Furst D.E., Breedveld F.C., and Kalden J.R. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor Necrosis Factor Trial in Rheumatoid Arthritis with concomitant Therapy Study Group N Engl J Med 343 2000 1594 1602
26. Smolen J.S., Emery P., Bathon J., Keystone E., Maini R.N., and Kalden J. Treatment of early rheumatoid arthritis with infliximab plus methotrexate or methotrexate alone:: preliminary results of the ASPIRE trial Ann Rheum Dis 62 suppl1 2003 64 (abstract)
27. Boers M., Verhoeven A.C., Markusse H.M., Vandelaar M.A., Westhose R., and Vandenderen J.C. Randomised comparison of combined step-down prednisolone methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis Lancet 350 1997 309 318
28. Vaneverdingen A.A., Jacobs J.W., Siewertsz Van Reesema D.R., and Bijlsm J.W. Low dose prednisolone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double blind, placebo-controlled clinical trial Ann Intern Med 136 2002 1 12